À¦°óSMÉçÇø

Heart & Stroke and À¦°óSMÉçÇø to create Early-Career Professorship in Women’s Heart Health

Montréal, June 18, 2019 – The first research chair in Quebec focused on women’s cardiac health, propelled by Heart & Stroke and À¦°óSMÉçÇø, will officially be launched on July 1 via a research project led by Dr. Natalie Dayan, Assistant Professor of Medicine at À¦°óSMÉçÇø’s Faculty of Medicine and Director of Obstetrical Medicine in the division of General Internal Medicine at the À¦°óSMÉçÇø Health Centre (MUHC).

Classified as: Cardiology, cardiovascular, Research Institute of the À¦°óSMÉçÇø Health Centre (RI-MUHC), Women's Health, Internal Medicine
Published on: 18 Jun 2019

A native Montrealer, Dr. Gabrielle Cassir completed her medical school and residency training at Université de Montreal. During her time as a medical student, she was also able to experience the American health care system, spending two months at Jackson Memorial Hospital in Miami. She completed two-years of subspecialty training in Maternal-Fetal Medicine at Mount Sinai Hospital in Toronto, before returning to Montreal where she recently became a staff physician in the Obstetrics and Gynecology division at St.

Classified as: Department of Obstetrics and Gynecology, Women's Health
Published on: 1 Mar 2019

A study conducted at the Research Institute of the À¦°óSMÉçÇø Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patients and may help them avoid unnecessary and invasive treatments. Using a database of 580 women with triple negative breast cancer (TNBC), the researchers found that survival was prolonged in patients who expressed the prolactin receptor and that prolactin hormone was able to reduce the aggressive behavior of cancerous cells. It does so by decreasing their ability to divide and form new tumors.

Classified as: RI-MUHC, breast cancer, Women's Health, Cancer Research Program
Category:
Published on: 25 Oct 2016
Back to top